SBL could be an innovative anti-cancer reagent because SBL induces apoptosis in cancer cells regardless of the P-glycoprotein expression and it exerts synergistic apoptosis-inducing effects with other molecules such as TRAIL and IFN-γ. Here, IFNG is linked to cancer.